Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
Emerging evidence suggests that both human stem cells and mature stromal cells can play an important role in the development and growth of human malignancies. In contrast to these tumor-promoting properties, we observed that in an in vivo model of Kaposi's sarcoma (KS), intravenously (i.v.) injected human mesenchymal stem cells (MSCs) home to sites of tumorigenesis and potently inhibit tumor growth. We further show that human MSCs can inhibit the in vitro activation of the Akt protein kinase within some but not all tumor and primary cell lines. The inhibition of Akt activity requires the MSCs to make direct cell–cell contact and can be inhibited by a neutralizing antibody against E-cadherin. We further demonstrate that in vivo, Akt activation within KS cells is potently down-regulated in areas adjacent to MSC infiltration. Finally, the in vivo tumor-suppressive effects of MSCs correlates with their ability to inhibit target cell Akt activity, and KS tumors engineered to express a constitutively activated Akt construct are no longer sensitive to i.v. MSC administration. These results suggest that in contrast to other stem cells or normal stromal cells, MSCs possess intrinsic antineoplastic properties and that this stem cell population might be of particular utility for treating those human malignancies characterized by dysregulated Akt.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There they can potentiate further tumorigenesis via differentiation into tumor-nurturing stroma (TAF, myofibroblasts) [82, 104], direct cell contact interaction with cancer cells [105, 106] or release of paracrine factors (Table 2).”
From Mesenchymal stem cell secretome and regenerative therapy after cancer (2013) · cites this paper as [106]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/Akt) signaling pathway in some cancer types [59].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [59]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Existing data from pre-clinical studies regarding the pro-apoptotic effect of MSCs on cancer cells through the downregulation of PI3K/Akt pathway support this antitumor potential in hepatocellular carcinoma, glioma cells, Kaposi's sarcoma, and prostate and breast cancer [61], [62], [63], [64], [65].”
From Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice (2019) · cites this paper as [61]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multilineage potential of adult human mesenchymal stem cells
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R. (1999) · Science · doi:10.1126/science.284.5411.143 · Cited by 21,052
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · cited 1×
“The myristoylated Akt plasmid (myrAkt) has been previously described (49)”
BackgroundStromal fibroblasts in cancer initiation and progression
Bhowmick, N. A., Neilson, E. G., & Moses, H. L. (2004) · Nature · doi:10.1038/nature03096 · Cited by 2,302
Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., & Chopp, M. (2001) · Stroke · doi:10.1161/01.str.32.4.1005 · Cited by 1,764
Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., & Ringdén, O. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00110-3 · Cited by 1,623
Cited by
Items 301–400 of 747
Seo, K., Lee, H. W., Oh, Y., Ahn, J., Koh, Y., Oh, S., Kang, S.-K., & Youn, H. (2011) · Cytotherapy · doi:10.3109/14653249.2011.584864 · Cited by 42
Du, J., Zhou, L., Chen, X., Yan, S., Ke, M., Lu, X., Wang, Z., Yu, W., & Xiang, A. P. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.04.015 · Cited by 41
Cai, T.-Y., Zhu, W., Chen, X., Zhou, S., Jia, L., & Sun, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1668 · Cited by 47
The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.
Yang, J., Ren, Z., Du, X., Hao, M., & Zhou, W. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2306-9759.2014.10.01 · Cited by 51
Lim, E.-J., Suh, Y., Yoo, K.-C., Lee, J.-H., Kim, I. G., Kim, M.-J., Chang, J. H., Kang, S., & Lee, S. (2016) · Oncotarget · doi:10.18632/oncotarget.13638 · Cited by 42
Mesenchymal Stem Cells and Cancer: Tumor-Specific Delivery Vehicles or Therapeutic Targets?
Dwyer, R. M., & Kerin, M. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.135 · Cited by 43
Tracking Intravenous Adipose-Derived Mesenchymal Stem Cells in a Model of Elastase-Induced Emphysema
Kim, Y. S., Kim, J.-Y., Shin, D., Huh, J. W., Lee, S. W., & Oh, Y. (2014) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2014.77.3.116 · Cited by 40
Mesenchymal stem cells enhance the metastasis of 3D-cultured hepatocellular carcinoma cells
Liu, C., Liu, Y., Xu, X., Guo, X. W., Sun, G., & Ma, X. (2016) · BMC Cancer · doi:10.1186/s12885-016-2595-4 · Cited by 45
Mesenchymal stem cells can induce regulatory T cells via modulating miR-126a but not miR-10a
Khosravi, M., Karimi, M. H., Aghdaei, M. H., Kalani, M., Naserian, S., & Bidmeshkipour, A. (2017) · Gene · doi:10.1016/j.gene.2017.06.012 · Cited by 38
Feng, H., Zhao, J., Schiergens, T. S., Wang, P., Ou, B., Al-Sayegh, R., Li, M.-L., Lu, A., Yin, S., & Thasler, W. E. (2018) · British Journal of Cancer · doi:10.1038/bjc.2017.415 · Cited by 41
Chulpanova, D. S., Solovyeva, V. V., James, V. H., Arkhipova, S. S., Gomzikova, M. O., Garanina, E. E., Akhmetzyanova, E. R., Tazetdinova, L. G., Khaiboullina, S. F., & Rizvanov, A. A. (2020) · Bioengineering · doi:10.3390/bioengineering7020059 · Cited by 42
Maurya, D. K., Doi, C., Kawabata, A., Pyle, M. M., King, C., Wu, Z., Troyer, D. L., & Tamura, M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-590 · Cited by 40
Kong, B. H., SHIN, H.-D., Kim, S. H., Mok, H.-S., Shim, J., Lee, J.-H., Shin, H.-J., Huh, Y., Kim, E. H., Park, E.-K., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1856 · Cited by 46
Clinical trials using dental stem cells: 2022 update
Song, W., Jin, L., Zhu, M., Wang, H., & Xia, D. (2023) · World Journal of Stem Cells · doi:10.4252/wjsc.v15.i3.31 · Cited by 53
Jin, S., Li, H., Mingzi, H., Ruan, M., Liu, Z., Zhang, F., Zhang, C., Choi, Y., & Liu, B. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000453166 · Cited by 40
Mesenchymal/stromal stem cells: necessary factors in tumour progression
Li, X., Fan, Q., Peng, X., Yang, S., Wei, S., Liu, J., Yang, L., & Li, H. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01107-0 · Cited by 43
Mesenchymal Stem Cells as Vectors for Lung Disease
Loebinger, M. R., Sage, E. K., & Janes, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200801-009aw · Cited by 42
Fritz, V., Noël, D., Bouquet, C., Opolon, P., Voide, R., Apparailly, F., Louis‐Plence, P., Bouffi, C., Drissi, H., Xie, C. L., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0139 · Cited by 38
Mesenchymal stem cells as carriers and amplifiers in CRAd delivery to tumors
Xia, X., Ji, T., Chen, P., Li, X., Fang, Y., Gao, Q., Liao, S., You, L.-Y., Xu, H., Ma, Q., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-134 · Cited by 44
Cell Therapy: A Novel Treatment Approach for Bronchopulmonary Dysplasia
Vosdoganes, P., Lim, R., Moss, T. J. M., & Wallace, E. M. (2012) · PEDIATRICS · doi:10.1542/peds.2011-2576 · Cited by 41
Guiho, R., Biteau, K., Grisendi, G., Taurelle, J., Chatelais, M., Gantier, M., Heymann, D., Dominici, M., & Redini, F. (2016) · International Journal of Cancer · doi:10.1002/ijc.30402 · Cited by 38
Mesenchymal Stromal Cells in Neuroblastoma: Exploring Crosstalk and Therapeutic Implications
Hochheuser, C., Windt, L. J., Kunze, N. Y., de Vos, D., Tytgat, G. A. M., Voermans, C., & Timmerman, I. (2021) · Stem Cells and Development · doi:10.1089/scd.2020.0142 · Cited by 38
Dzobo, K., Vogelsang, M., Thomford, N. E., Dandara, C., Kallmeyer, K., Pepper, M. S., & Parker, M. I. (2016) · Stem Cells International · doi:10.1155/2016/4842134 · Cited by 39
Shou, P., Chen, Q., Jiang, J., Xu, C., Zhang, J., Zheng, C., Jiang, M.-T., Velletri, T., Cao, W., Huang, Y., et al. (2016) · Oncogene · doi:10.1038/onc.2016.128 · Cited by 42
Self-citationRogers, T. B., Pati, S., Gaa, S. A., Riley, D. D., Khakoo, A. Y., Patel, S. S., Wardlow, R. D., Frederick, C. A., Hall, G., He, L.-P., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.09.001 · Cited by 38
Self-citationBone marrow mesenchymal stem cells promote osteosarcoma cell proliferation and invasion
Yu, F.-X., Hu, W.-J., He, B., Zheng, Y.-H., Zhang, Q.-Y., & Chen, L. (2015) · World Journal of Surgical Oncology · doi:10.1186/s12957-015-0465-1 · Cited by 37
Inhibition of HSP90 could be possible mechanism for anti-cancer property of amniotic membrane
Niknejad, H., Yazdanpanah, G., Mirmasoumi, M., Abolghasemi, H., Peirovi, H., & Ahmadiani, A. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.08.018 · Cited by 39
Gauthaman, K., Fong, C., Arularasu, S. C., Subramanian, A., Biswas, A., Choolani, M. A., & Bongso, A. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24367 · Cited by 42
Therapeutic potential of stem cells in lung disease: progress and pitfalls
Loebinger, M. R., Aguilar, S., & Janes, S. M. (2007) · Clinical Science · doi:10.1042/cs20070073 · Cited by 45
Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice
Stamatopoulos, A., Stamatopoulos, T., Gamie, Z., Kenanidis, E., Ribeiro, R. D. C., Rankin, K. S., Gerrand, C., Dalgarno, K., & Tsiridis, E. (2019) · Journal of Bone Oncology · doi:10.1016/j.jbo.2019.100231 · Cited by 37
“The anti-tumorigenic and pro-apoptotic effect of MSCs results from the suppression of the phosphoinositide 3-kinase/protein kinase B (PI3K/ Akt) signaling pathway in some cancer types [59].”
BackgroundMultipotent Mesenchymal Stromal Cells: Clinical Applications and Cancer Modeling
Rodríguez, R., García-Castro, J., Trigueros, C., Arranz, M. G., & Menéndez, P. R. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2098-9_13 · Cited by 44
Fakiruddin, K. S., Lim, M. N., Nordin, N., Rosli, R., Zakaria, Z., & Abdullah, S. (2019) · Cancers · doi:10.3390/cancers11091261 · Cited by 38
Tumor–stromal interactions in lung cancer: novel candidate targets for therapeutic intervention
El-Nikhely, N. A., Larzábal, L., Seeger, W., Calvo, A., & Savai, R. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.693478 · Cited by 40
Deng, L., Li, H., Su, X., Zhang, Y., Xu, H., Fan, L., Fan, J., Han, Q., Bai, X., & Zhao, R. C. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2357-8 · Cited by 37
Novel aspects of parenchymal–mesenchymal interactions: from cell types to molecules and beyond
Blüguermann, C., Wu, L., Petrigliano, F. A., McAllister, D. R., Miriuka, S., & Evseenko, D. A. (2013) · Cell Biochemistry and Function · doi:10.1002/cbf.2950 · Cited by 37
Adipose tissue-derived stem cells promote pancreatic cancer cell proliferation and invasion
Ji, S. Q., Cao, J., Zhang, Q. Y., Li, Y., Yan, Y., & Yu, F. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20132907 · Cited by 39
Werner, S., Lützkendorf, J., Müller, T., Müller, L. P., & Posern, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-48142-z · Cited by 38
Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors
Chan, J. K. Y., & Lam, P. Y. P. (2013) · Cancer Gene Therapy · doi:10.1038/cgt.2013.59 · Cited by 37
Wnt signalling in mouse mesenchymal stem cells: impact on proliferation, invasion and MMP expression
Karow, M., Popp, T., Egea, V., Ries, C., Jochum, M., & Neth, P. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00619.x · Cited by 41
Hu, M., Yang, J.-L., Teng, H., Jia, Y.-Q., Wang, R., Zhang, X., Wu, Y., Luo, Y., Chen, X.-C., Zhang, R., et al. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-306 · Cited by 34
Vulcano, F., Milazzo, L., Ciccarelli, C., Eramo, A., Sette, G., Mauro, A., Macioce, G., Martinelli, A., Torre, R. L., Casalbore, P., et al. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.06.003 · Cited by 33
Aboulhoda, B. E., & Fattah, S. A. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2879-x · Cited by 35
Molecular characteristics of bone marrow mesenchymal stem cells, source of regenerative medicine
Pourrajab, F., Forouzannia, S. K., & Tabatabaee, S. A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.017 · Cited by 35
Ma, B., Jiang, H., Jia, J., Di, L., Song, G., Yu, J., Zhu, Y., Lü, Z., Wang, X., Zhou, X., et al. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0860-9 · Cited by 33
Mesenchymal Stem Cells as Vectors for Lung Cancer Therapy
Kolluri, K. K., Laurent, G. J., & Janes, S. M. (2013) · Respiration · doi:10.1159/000351284 · Cited by 34
Cortes‐Dericks, L., Froment, L., Kocher, G. J., & Schmid, R. A. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0282-7 · Cited by 34
Lin, H. D., Fong, C., Biswas, A., Choolani, M. A., & Bongso, A. (2016) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25501 · Cited by 34
Bone Marrow Cell Therapy on 1,2-Dimethylhydrazine (DMH)-Induced Colon Cancer in Rats
El‐Khadragy, M. F., Nabil, H. M., Hassan, B. N., Tohamy, A. A., Waer, H. F., Yehia, H. M., Alharbi, A., & Moneim, A. E. A. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000487349 · Cited by 33
Stem cell therapy for faecal incontinence: Current state and future perspectives
Trébol, J., Carabias-Orgaz, A., García‐Arranz, M., & García‐Olmo, D. (2018) · World Journal of Stem Cells · doi:10.4252/wjsc.v10.i7.82 · Cited by 31
Seyhoun, I., Hajighasemlou, S., Muhammadnejad, S., Ai, J., Nikbakht, M., Alizadeh, A. A., Hosseinzadeh, F., Mirmoghtadaei, M., Seyhoun, S. M., & Verdi, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27637 · Cited by 31
The Immunomodulatory Properties of Mesenchymal Stem Cells: Implications for Surgical Disease
Weil, B. R., Manukyan, M. C., Herrmann, J. L., Abarbanell, A. M., Poynter, J. A., Wang, Y., & Meldrum, D. R. (2010) · Journal of Surgical Research · doi:10.1016/j.jss.2010.07.019 · Cited by 37
Song, J., Zhu, J. W., Jiang, Y., Guo, Y., Liu, S., Qiao, Y., Du, Y., & Li, J. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189277 · Cited by 36
Mr, M., Lj, D., & Gl, W. (2014) · Cancer Gene Therapy · doi:10.1038/cgt.2013.83 · Cited by 33
Effect of bone marrow–derived mesenchymal stromal cells on hepatoma
Abd-Allah, S. H., Shalaby, S. M., El‐Shal, A. S., Elkader, E. A., Hussein, S., Emam, E., Mazen, N. F., Kateb, M. E., & Atfy, M. (2014) · Cytotherapy · doi:10.1016/j.jcyt.2014.05.006 · Cited by 32
Schug, C., Gupta, A., Urnauer, S., Steiger, K., Cheung, P. F., Neander, C., Savvatakis, K., Schmohl, K. A., Trajkovic‐Arsic, M., Schwenk, N., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0185 · Cited by 34
Could cancer and infection be adverse effects of mesenchymal stromal cell therapy?
Arango-Rodríguez, M. L., Ezquer, F., Ezquer, M., & Conget, P. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.408 · Cited by 33
Umbilical cord-derived mesenchymal stem cells inhibit growth and promote apoptosis of HepG2 cells
Tang, Y., Bao, W.-M., Yang, J., Ma, L., Yang, J., Xu, Y., Yang, L., Sha, F., Xu, Z.-Y., Wu, H.-M., et al. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5537 · Cited by 35
Adult mesenchymal stromal stem cells for therapeutic applications
Spitkovsky, D., & Hescheler, J. (2008) · Minimally Invasive Therapy & Allied Technologies · doi:10.1080/13645700801969758 · Cited by 41
Al-Toub, M., Vishnubalaji, R., Hamam, R., Kassem, M. S., Aldahmash, A. M., & Alajez, N. M. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0123-0 · Cited by 29
Amniotic fluid-derived mesenchymal stem cells: characteristics and therapeutic applications
Zhou, J., Wang, D., Liang, T., Guo, Q., & Zhang, G. (2014) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-014-3231-7 · Cited by 31
Bianchi, G., Morandi, F., Cilli, M., Daga, A., Bocelli‐Tyndall, C., Gambini, C., Pistoia, V., & Raffaghello, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048654 · Cited by 29
The therapeutic potential of mesenchymal stem cells in lung cancer: benefits, risks and challenges
Cortes‐Dericks, L., & Galetta, D. (2019) · Cellular Oncology · doi:10.1007/s13402-019-00459-7 · Cited by 30
Di, G., Jiang, S., Li, F.-Q., Sun, J., Wu, C.-T., Hu, X., & Duan, H. (2012) · Cytotherapy · doi:10.3109/14653249.2011.646044 · Cited by 28
Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial
Bolli, R., Hare, J. M., Henry, T. D., Lenneman, C. G., March, K. L., Miller, K. D., Pepine, C. J., Perin, E. C., Traverse, J. H., Willerson, J. T., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.02.009 · Cited by 29
Human Bone Marrow-Derived Mesenchymal Stem Cells
Nasef, A., Fouillard, L., Taguri, A. E., & Lopez, M. (2007) · Libyan Journal of Medicine · doi:10.3402/ljm.v2i4.4729 · Cited by 34
Mesenchymal stem cell-based gene therapy: A promising therapeutic strategy
Mohammadian, M., Abasi, E., & Akbarzadeh, A. (2015) · Artificial Cells Nanomedicine and Biotechnology · doi:10.3109/21691401.2015.1029624 · Cited by 33
Cheng, J., Yang, K., Zhang, Q., Yu, Y., Meng, Q., Mo, N., Zhou, Y., Yi, X., Ma, C., Lei, A., et al. (2016) · Scientific Reports · doi:10.1038/srep16993 · Cited by 30
Al-Toub, M., Almohawes, M., Vishnubalaji, R., Alfayez, M. A., Aldahmash, A. M., Kassem, M. S., & Alajez, N. M. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0169-3 · Cited by 31
Cellular plasticity and drug resistance in sarcoma
Lin, Z., Fan, Z., Zhang, X., Wan, J., & Liu, T. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118589 · Cited by 30
Khorrami, S. M. S., Soleimanjahi, H., Soudi, S., & Habibian, A. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01848-5 · Cited by 33
Rolfo, A., Giuffrida, D., Giuffrida, M. C., Todros, T., & Calogero, A. E. (2014) · The Aging Male · doi:10.3109/13685538.2014.896894 · Cited by 29
Kikuchi, H., Yagi, H., Hasegawa, H., Ishii, Y., Okabayashi, K., Tsuruta, M., Hoshino, G., Takayanagi, A., & Kitagawa, Y. (2014) · Journal of Surgical Research · doi:10.1016/j.jss.2014.02.047 · Cited by 30
Wharton's Jelly Stem Cells as Agents for Cancer Therapy
Tamura, M. (2011) · The Open Tissue Engineering and Regenerative Medicine Journal · doi:10.2174/1875043501104010039 · Cited by 30
Tracking Inflammation-Induced Mobilization of Mesenchymal Stem Cells
Spaeth, E. L., Kidd, S. M., & Marini, F. C. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-943-3_15 · Cited by 29
Zheng, H., Zou, W., Shen, J., Xu, L., Wang, S., Fu, Y.-X., & Fan, W. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0300 · Cited by 28
Mesenchymal Stem Cells in the Induction of Transplantation Tolerance
Bartholomew, A. M., Polchert, D., Szilagyi, E., Douglas, G. W., & Kenyon, N. S. (2009) · Transplantation · doi:10.1097/tp.0b013e3181a287e6 · Cited by 28
Betancourt, A. M. (2012) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2012_141 · Cited by 34
Afkhami, H., Mahmoudvand, G., Fakouri, A., Shadab, A., Mahjoor, M., & Komeili Movahhed, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1255697 · Cited by 27
Cells As Delivery Vehicles for Cancer Therapeutics
Basel, M. T., Shrestha, T. B., Bossmann, S. H., & Troyer, D. L. (2014) · Therapeutic Delivery · doi:10.4155/tde.14.24 · Cited by 28
Tumor microenvironment and the role of mesenchymal stromal cells
KUCEROVA, L., & SKOLEKOVA, S. (2012) · Neoplasma · doi:10.4149/neo_2013_001 · Cited by 27
Lim, E.-J., Suh, Y., Kim, S., Kang, S., & Lee, S. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.4.185 · Cited by 29
Safety Considerations in 3D Bioprinting Using Mesenchymal Stromal Cells
Belk, L., Tellisi, N., Macdonald, H., Erdem, A., Ashammakhi, N. A., & Pountos, I. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00924 · Cited by 32
Cheng, J., Duan, L.-X., Yu, Y., Wang, P., Feng, J.-L., Feng, G. Z., & Liu, Y. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00599-0 · Cited by 31
Safari, F., Shakery, T., & Sayadamin, N. (2021) · Cell Biochemistry and Function · doi:10.1002/cbf.3654 · Cited by 29
Altanerová, V., Horváthová, E., Matúšková, M., Kučerová, L., & Altaner, Č. (2009) · Neoplasma · doi:10.4149/neo_2009_06_542 · Cited by 28
Mesenchymal Stem Cells as New Therapeutic Approach for Diabetes and Pancreatic Disorders
Scuteri, A., & Monfrini, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092783 · Cited by 27
Yang, B., Jiao, H., Guan, F., Li, J., Shan, H., Song, L., Hu, X., & Du, Y. (2011) · Neurology India · doi:10.4103/0028-3886.79134 · Cited by 26
Mesenchymal stromal cells as a drug delivery system
Menon, L. G., Shi, V. J., & Carroll, R. S. (2009) · doi:10.3824/stembook.1.35.1 · Cited by 30
Li, M., Cai, H., Yang, Y. P., Zhang, J., Sun, K., Yan, Y., Qu, H., Wang, W., Wang, J., & Duan, X. (2016) · Oncology Reports · doi:10.3892/or.2016.4853 · Cited by 27
Self-citationVisweswaran, M., Arfuso, F., Dilley, R. J., Newsholme, P., & Dharmarajan, A. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.12.013 · Cited by 27
Ai, J., Ketabchi, N., Verdi, J., Gheibi, N., Haghighian, H. K., & Kavianpour, M. (2019) · Cancer Cell International · doi:10.1186/s12935-019-1038-0 · Cited by 28
Ramuta, T. Ž., & Kreft, M. E. (2022) · Cancers · doi:10.3390/cancers14153761 · Cited by 31
Niu, P., Smagul, A., Wang, L., Sadvakas, A., Sha, Y., Pérez, L. M., Nussupbekova, A., Amirbekov, A., Akanov, A. A., Gálvez, B. G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4852 · Cited by 26
Hendijani, F. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2014.10.015 · Cited by 27
Liu, B., Chen, F., Wu, Y. C., Wang, X., Feng, M., Li, Z., Zhou, M., Wang, Y., Wu, L., Liu, X., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16584 · Cited by 27
Bai, H., Weng, Y., Bai, S., Jiang, Y., LI, B., He, F., Zhang, R., Yan, S., Deng, F., Wang, J., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2421 · Cited by 26
Delinassios, J. G., Angeli, F., Koumakis, G., Kumar, S., Kang, W.-H., Sica, G., Iacopino, F., Lama, G., Lamprecht, S. A., Sigal-Batikoff, I., et al. (2015) · PubMed · Cited by 26
Placenta‐Derived Mesenchymal Stem Cells for Treatment of Diseases: A Clinically Relevant Source
Moonshi, S. S., Adelnia, H., Wu, Y., & Ta, H. T. (2022) · Advanced Therapeutics · doi:10.1002/adtp.202200054 · Cited by 30
Stem Cell Based Gene Therapy in Prostate Cancer
Kim, J. H., Lee, H. J., & Song, Y. S. (2014) · BioMed Research International · doi:10.1155/2014/549136 · Cited by 28
The dual role of mesenchymal stem cells in tumor progression
Gomes, C. M. F. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt189 · Cited by 25
Metadata
- Authors
- Khakoo, A. Y., Pati, S., Anderson, S. A., Reid, W., Elshal, M. F., Rovira, I. I., Nguyen, A. T., Malide, D., Combs, C. A., Hall, G., Zhang, J., Raffeld, M., Rogers, T. B., Stetler-Stevenson, W., Frank, J. A., Reitz, M., & Finkel, T.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Maryland Biotechnology Institute (US)
- National Institutes of Health (US)
- Flow Cytometry Core Facility (CH)
- 1Laboratory of Molecular Biology, Cardiovascular Branch,
- National Heart, Lung, and Blood Institute (US)
- University of Maryland, Baltimore (US)
- National Cancer Institute (UA)
- 4National Cancer Institute; and
- ORCID
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-24
- Volume
- 203
- Issue
- 5
- Pages
- 1235-1247
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2121206
- OpenAlex
- W2163234891
- Cited by
- 747
- References
- 60
- Citations by year
- 2026: 6 · 2025: 16 · 2024: 20 · 2023: 31 · 2022: 25 · 2021: 34 · 2020: 37 · 2019: 41 · 2018: 38 · 2017: 28 · 2016: 53 · 2015: 56 · 2014: 38 · 2013: 79 · 2012: 51
- FWCI
- 14.63
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute
- National Cancer Institute (1R01 CA09905-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Keywords
- mesenchymal stem cells, Kaposi's sarcoma, anticancer activity, Akt signaling, E-cadherin, cell-cell contact, tumor stroma, stem cell homing, tumor suppression, stem cell therapy
- MeSH terms
- Animals, Disease Models, Animal, Enzyme Activation, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Experimental, Sarcoma, Kaposi, Transplantation, Heterologous, Tumor Cells, Cultured, Stromal Cells, Graft vs Tumor Effect, Mesenchymal Stem Cell Transplantation, Oncogene Protein v-akt, Mice, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.